Citation Impact
Citing Papers
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
Expanding the Biologist’s Toolkit with CRISPR-Cas9
2015 StandoutNobel
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
2019 StandoutNobel
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
2014
Immunogenicity of therapeutic proteins: Influence of aggregation
2013
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
2016 StandoutNobel
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
2017
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
2017 StandoutNobel
Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering
2016 StandoutNobel
RNA-dependent RNA targeting by CRISPR-Cas9
2018 StandoutNobel
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with mucopolysaccharidosis type VII
2020
Natural product and natural product derived drugs in clinical trials
2014 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
2019 Standout
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
2014 StandoutNobel
Works of Anne Pariser being referenced
Rare Cancer Trial Design: Lessons from FDA Approvals
2012
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
2008
The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe disease
2012